Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Xo Biologix
WARNING LETTER
•Xo Biologix•January 5, 2024

Xo Biologix – FDA Warning Letter, Jan 5, 2024

Record Details

The FDA inspected the facility at 609 Castle Ridge Rd, Suite 400, Austin, TX, from January 3-5, 2024. The company markets and distributes MaviX™, an amniotic fluid-derived product. The FDA determined MaviX™ is an unapproved new drug, an unlicensed biological product, adulterated, and misbranded.

MaviX™ is an unapproved new drug under section 505(a) of the FD&C Act and an unlicensed biological product under section 351(a)(1) of the PHS Act because it lacks an approved Biologics License Application (BLA). Promotional materials and the company website claim MaviX™ "Helps reduce pain, inflammation, and regenerate tissue," and is "Anti-Inflammatory" and "Anti-Fibrotic," indicating drug and biological product intent.

The product is adulterated due to significant Current Good Manufacturing Practice (CGMP) violations, as detailed in Warning Letter CBER 25-679023, violating section 501(a)(2)(B) of the FD&C Act and 21 CFR parts 210 and 211. The firm is responsible for CGMP compliance regardless of manufacturing location.

MaviX™ is misbranded under section 502(a) of the FD&C Act. The Instructions for Use (

Company
Xo Biologix
Inspection date
January 5, 2024
Product type
Biologics
Office
Center for Biologics Evaluation and Research
Person
  • Melissa J. Mendoza (Director)
View Company Profile

ID · 22b8160b-8f52-4e31-bd0d-50453694c778

Violation Codes8
21 U.S.C. 351(a)(2)(B)21.U.S.C. 355(a)21 U.S.C. 331(d)21 CFR 21021 CFR 21121 U.S.C. 352(a)21 U.S.C. 321(g)(1)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Other documents for Xo Biologix
  • EIR - 2024-01-05January 5, 2024

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Xo Biologix
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.